Opendata, web and dolomites

OSTOF SIGNED

Ostoform; Using advanced material combinations to improve ostomy skin health.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "OSTOF" data sheet

The following table provides information about the project.

Coordinator
OSTOFORM LIMITED 

Organization address
address: BLOCK A MARLINSTOWN OFFICE PARK
city: MULLINGAR CO WESTMEATH
postcode: N91 W5NN
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://www.ostoform.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2018-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OSTOFORM LIMITED IE (MULLINGAR CO WESTMEATH) coordinator 50˙000.00

Map

 Project objective

Ostoform is a spin-out medical device company from the University of Limerick, Ireland with a range of patented technologies, and the potential to scale, becoming a global leader in the area of ostomy skin health. There is enormous opportunity to address needs in the ostomy market, with 66% of all ileostomy and urostomy patients suffering from skin complications. The company’s first, award winning product, uses a combination of advanced absorbent and non-absorbent materials to prevent acidic output from contacting the patient’s skin. Benefits of this product include healthier skin, better usability, increased patient confidence and improved patient quality of life. Ostoform will release this product in 2018, and major ostomy companies, including B Braun and For Life have already expressed strong interest in distribution. The addressable patient population for Ostoform’s first product is approximately 1,000,000 in the EU and US combined, resulting in an annual market of $725m. The device is typically reimbursed by healthcare systems, resulting in a smoother route to market. This feasibility study will be used to further develop a global reimbursement and go-to-market strategy for Ostoform’s first product. It will also assist in establishing a final cost of manufacture for the device.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OSTOF" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OSTOF" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

HelpingHAND (2018)

A 3D printed, affordable myoelectrical prosthetic hand of personalizeable size for optimal comfort and functionality

Read More  

HIL PT System (2017)

Revolutionary, cost effective, spatially efficient, proton therapy system for cancer treatment.

Read More